Key facts
- Cascador Health’s last known valuation is $19.8M (Sep 2025).
- It has raised $13.4M; the latest was Early Stage VC ($5.4M) in Sep 2025.
- Notable investors include Imec.istart, 50 North Ventures, Ethias Ventures, Hirslanden, Qbic Fund — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Cascador Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Cascador Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Cascador Health
Developer of a healthcare data platform designed to bridge the gap between data providers and the research industry. The company's platform offers insight into therapeutic outcomes, site selection for clinical studies, monitoring safety and adverse effects, or optimizing processes in a hospital, enabling healthcare providers and life science industry clients to access structured, validated, and anonymized real-world data to provide better care.
- Sector
- Healthcare
- HQ
- Tielrode, Belgium
- Founded
- 2021
- Employees
- 20
- Website
- cascador.health/
- Ownership
- Privately Held (backing)
Cascador Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cascador Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cascador Health in its N-PORT filings yet. We sweep new filings monthly.